This is mainly due to the pre-screen procedure used in this study, the top ranking 96 tumours in the pre-screen procedure during the sample collection not only enriched for BRAF mutated samples, but also enriched for BRAF wild-type samples that are true BRAF-mutation-like subtype. The gene discussed is BRAF; the disease is neoplasm.